Free Trial

What is Cormark's Forecast for kneat.com FY2025 Earnings?

kneat.com logo with Medical background

kneat.com, inc. (TSE:KSI - Free Report) - Cormark lowered their FY2025 earnings per share estimates for kneat.com in a research note issued on Tuesday, July 22nd. Cormark analyst G. Fairweather now expects that the company will post earnings per share of ($0.01) for the year, down from their prior estimate of $0.01. The consensus estimate for kneat.com's current full-year earnings is ($0.12) per share. Cormark also issued estimates for kneat.com's FY2026 earnings at $0.03 EPS and FY2027 earnings at $0.12 EPS.

kneat.com Stock Down 1.8%

TSE:KSI traded down C$0.10 during mid-day trading on Wednesday, reaching C$5.60. The stock had a trading volume of 45,802 shares, compared to its average volume of 86,208. The company has a market capitalization of C$523.61 million, a price-to-earnings ratio of -60.49, a price-to-earnings-growth ratio of 597.67 and a beta of 1.08. kneat.com has a 1-year low of C$4.30 and a 1-year high of C$7.25. The stock's 50 day simple moving average is C$6.18 and its two-hundred day simple moving average is C$6.30. The company has a debt-to-equity ratio of 85.50, a current ratio of 1.43 and a quick ratio of 1.50.

kneat.com Company Profile

(Get Free Report)

kneat.com Inc is in the business of developing and marketing a software application for modelling regulated data-intensive processes for regulated industries, focusing on the life sciences industry. The company has developed Kneat Gx solution which provides management real-time visibility and control and increases product, quality, and compliance.

Recommended Stories

Earnings History and Estimates for kneat.com (TSE:KSI)

Should You Invest $1,000 in kneat.com Right Now?

Before you consider kneat.com, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and kneat.com wasn't on the list.

While kneat.com currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines